Erratum to: Serum IL-33, a new marker predicting response to rituximab in rheumatoid arthritis - Sorbonne Université Access content directly
Journal Articles Arthritis Research & Therapy Year : 2017

Erratum to: Serum IL-33, a new marker predicting response to rituximab in rheumatoid arthritis

Edward Vital
  • Function : Author
Paul Emery
  • Function : Author
Martin Soubrier

Abstract

No abstract available

Dates and versions

hal-04000529 , version 1 (22-02-2023)

Identifiers

Cite

Jérémie Sellam, Elodie Rivière, Alice Courties, Paul-Olivier Rouzaire, Barbara Tolusso, et al.. Erratum to: Serum IL-33, a new marker predicting response to rituximab in rheumatoid arthritis. Arthritis Research & Therapy, 2017, 19 (1), pp.11. ⟨10.1186/s13075-017-1221-4⟩. ⟨hal-04000529⟩
12 View
0 Download

Altmetric

Share

Gmail Facebook X LinkedIn More